Letter

In Finland anticoagulant treatment is monitored by general practitioners

BMJ 1996; 312 doi: 10.1136/bmj.312.7022.52b (Published 6 January 1996)
Cite this as: BMJ 1996;312:52.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. K Eskola,
  2. I Virjo,
  3. M Isokoski,
  4. Pirjo Aittobiemi,
  5. H Kurunmaki,
  6. A Latva-Nevala,
  7. M Paloneva,
  8. A-M Wallin,
  9. M Viitaniemi,
  10. S Ylinen,
  11. S Ohman
  1. (senior lecturer in general practice), (acting assistant professor of general practice), (professor of primary health care), Department of Public Health, University of Tampere, Tampere, Finland; (general practitioner), Health Centre, Seinajoki; (general practitioner), Health Centre, Kurikka; (chief physician), Health Centre, Seinajoki; (general practitioner), Health Centre, Vaasa; (general practitioner), Health Centre, Oravainen; (chief physician), Health Centre, Seinajoki; (general practitioner), Health Centre, Ahtari; (chief physician), Health Centre, Vaasa

    EDITOR,—C M Sudlow and colleagues emphasise the importance of an understanding of “the whole package of care” when new research evidence concerning the effect of anticoagulant treatment in preventing strokes in patients with atrial fibrillation is applied to everyday work.1 In their commentary on the article K G Sweeney and colleagues are worried about complications of the treatment and about underanticoagulation.1 2

    In Finland anticoagulant treatment is monitored by general practitioners in primary health care. In some cases they also start the treatment. The country thus has a system that Sweeney et …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular